24th Nov 2025 12:28
TRISTEL plc
("Tristel" or the "Company")
Director Option Grant
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that on 24 November 2025 it granted a total of 181,972 new share options (the "Options") over ordinary shares of 1 pence each ("Ordinary Shares") under the Long Term Incentive Plan ("LTIP") in the Company, to two directors as follows:
Director's name | Position | Number of Options granted | Aggregate number of options post grant | Current total beneficial holding of Ordinary Shares | Current holding as a % of Issued share capital |
Matt Sassone | CEO | 106,479 | 183,483 | 3,500 | 0.01% |
Anna Wasyl | CFO | 75,493 | 75,493 | 0 | 0% |
Terms of the new LTIP
The performance targets for the LTIP awards, which have been adjusted to reflect the impact of the tax rate and the investments required to stimulate growth, will be 50% based on earning per share (EPS) targets and 50% based on relative total shareholder return (TSR) versus the constituents of the AIM 100 as at the grant of the awards as follows:
50% of Initial awards | 50% of Initial awards |
| ||
EPS FY 27/28 | % of EPS Part that Vests | Relative TSR measured over 3 years from grant | % of TSR Part that Vests | |
Less than 19p | 0% | Below median | 0% | |
Between 19p and 23p | Pro-rata 25% to 100% | Between median and upper quartile | Pro-rata 25% to 100% | |
23p or better | 100% | Upper quartile or above | 100% | |
This announcement was deemed by the company to contain inside information as stipulated under the Market Abuse Regulations (EU) no. 596/2014 as they form part of UK domestic law by virtue of the European Union (withdrawal) Act 2018. With the publication of this announcement, this information is now considered to be in the public domain.
For further information please contact:
Tristel plc | Via Walbrook PR | ||
Matt Sassone, Chief Executive Officer | www.investors.tristel.com | ||
Anna Wasyl, Chief Financial Officer | |||
Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] | ||
Paul McManus / Lianne Applegarth / Anna Dunphy | Mob: 07980 541 893/ 07584 391 303/ 07876 741 001 | ||
Cavendish Capital Markets Ltd | Tel: 020 7220 0500 | ||
Geoff Nash / Callum Davidson / Trisyia Jamaludin (Corporate Finance) | |||
Sunila de Silva (Corporate Broking) / Louise Talbot (Sales) | |||
About Tristel plc
Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, a more sustainable alternative to commonly used pre-wetted plastic wipes.
Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 270 people across 20 subsidiaries selling into 40+ countries. The Company targets double digit revenue growth annually and an EBITDA margin of at least 25% and the business is profitable, with no debt and has a progressive dividend policy.
The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).
For more information about Tristel's product range please visit: https://tristel.com
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014 which forms part of UK Law by virtue of the European Union (Withdrawal) Act 2018.
1. | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Matthew Sassone |
2. | Reason for the Notification | |
a) | Position/status | CEO |
b) | Initial notification/Amendment | Initial notification |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Tristel plc |
b) | LEI | 2138009DZ4LH9CZGF662 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the Financial instrument, type of instrument | Ordinary shares of 1p each |
Identification code | GB00B07RVT99 | |
b) | Nature of the transaction | Grant of options |
c) | Price(s) and volume(s) | 1 pence, 106,479 shares
|
d) | Aggregated information: · Aggregated volume · Price | See above
|
e) | Date of the transaction | 24 November 2025 |
f) | Place of the transaction | Outside of a trading venue |
1. | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Anna Wasyl |
2. | Reason for the Notification | |
a) | Position/status | CFO |
b) | Initial notification/Amendment | Initial notification |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Tristel plc |
b) | LEI | 2138009DZ4LH9CZGF662 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the Financial instrument, type of instrument | Ordinary shares of 1p each |
Identification code | GB00B07RVT99 | |
b) | Nature of the transaction | Grant of options |
c) | Price(s) and volume(s) | 1 pence, 75,493 shares
|
d) | Aggregated information: · Aggregated volume · Price | See above
|
e) | Date of the transaction | 24 November 2025 |
f) | Place of the transaction | Outside of a trading venue |
Related Shares:
Tristel